structure of tirzepatide Development and the corresponding chemical Designing a dual GLP-1R/GIPR agonist

Orforglipron demonstrated significant improvements in weight reduction, glycemic control, lipid profile, and blood pressure compared with placebo

Schedule a free consultation with a registered dietitian who can help you optimize your nutrition, manage side effects, and lose weight safely and effectively while using a GLP-1 medication, all at no cost to you

While this medication is not yet accessible, similar treatments like Wegovy and Zepbound are currently available, and insurance can help cover these options

Lancet Diabetes Endo 12:653663 Leslie WS, Ali E, Harris L et al (2021) Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)

Novo Nordisks PAP is only available for those with a diagnosis of type 2 diabetes

Lillys Orforglipron Helped People Maintain Weight Loss After Switching From Injectable Incretins to Oral GLP-1 Therapy in First-of-Its-Kind Phase 3 Trial